Tag : Defying

Latest News

Defying analyst expectations, Eisai launches study of a-beta drug BAN 2401 in Alzheimer’s

After Thursday’s halt to aducanumab’s development dealt a significant blow to the amyloid beta hypothesis in Alzheimer’s, analysts had expected BAN 2401 – developed under...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy